Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases
Conclusions Clinicians prescribing antidepressants, mood stabilizers/anticonvulsants, and benzodiazepines, should be aware of the probable risk of drug-drug interaction with COVID-19 medications and may benefit from heeding these recommendations for use to ensure patient safety. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: Pharmacopsychiatry - Category: Psychiatry Authors: Plasencia-Garc Ãa, Beatriz Oda Rico-Rangel, Mar Ãa Isabel Rodr Ãguez-Menéndez, Gonzalo Rubio-Garc Ãa, Ana Torell ó-Iserte, Jaime Crespo-Facorro, Benedicto Tags: Review Source Type: research
More News: Actemra | Azithromycin | Coronavirus | COVID-19 | Cymbalta | Databases & Libraries | Dexamethasone | Gabapentin | Hydroxychloroquine | Kaletra | Lithium | Lyrica | Men | Neurontin | Norvir | Pandemics | Pristiq | Psychiatry | SARS | Topamax | Zithromax